Larvol Delta - ViralClear-Expands-Ongoing-Phase-2-Trial-Size-for-its-Oral-AntiViral-for-the-Treatment-of-COVID19-Expands-Trial-Locations-and-Appoints-Contract-Manufacturing-Organization-to-Manufacture-Phase-3-Supplies-of-Merimepodib-Oral-Solution

Vicromax (merimepodib) - BioSig Tech

remdesivir - Generic mfg.

https://www.globenewswire.com/news-release/2020/09/22/2097413/0/en/ViralClear-Expands-Ongoing-Phase-2-Trial-Size-for-its-Oral-Anti-Viral-for-the-Treatment-of-COVID-19-Expands-Trial-Locations-and-Appoints-Contract-Manufacturing-Organization-to-Manu.html

Sep 22, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next